Yersinia rohdei

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Yersinia rohdei is a Gram-negative, non-spore-forming, facultatively anaerobic, variably-motile, coccobacillus bacterium. It has been detected in at least 2 gut microbiome compilation studies or metastudies. The DNA G+C content is 49.1%. Yersinia rohdei is probably a rare gut coloniser. (Eksic1987; Bottone2005Bergey)



  • This organism has been recovered from human faeces. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread (notes: opportunistic in immunocompromised patients). Can cause opportunistic infections, particularly in immunocompromised people. A possible gut commensal.
    • GENERAL CHARACTERISTICS (Eksic1987); (Bottone2005Bergey);
    Character Response
  • ±
  • Strain-dependent hydrolysis or digestion:
  • urea;
  • 🌡
  • Temperature tolerance:
  • Grows optimally at 28-29℃.
  • H+
  • Acid from carbohydrates usually produced:
  • glucose; xylose; sucrose; trehalose; mannitol; sorbitol;
  • ±
  • Strain-dependent acid from carbs:
  • melibiose; raffinose;
  • Active enzymes:
  • α-galactosidase; β-galactosidase;
  • ±
  • Strain-dependent active enzymes:
  • urease;
    • SPECIAL FEATURES (Eksic1987); (Bottone2005Bergey);
    Character Response
  • ✗
  • Metabolites not produced:
  • H₂S; indole;
  • ✓
  • Methyl red test:
  • active
  • ✗
  • VP test:
  • not active
  • KCN growth:
  • inhibited
  • ✓
  • NO3➔NO2:
  • reduced
    • RESPONSE TO ANTIBIOTICS (Eksic1987); (Bottone2005Bergey);
    Class Active Resistant
  • Penicillins:
  • aztreonam; imipenem;
  • ampicillin; carbenicillin; penicillin G;
  • Cephalosporins:
  • cephalothin;
  • Macrolides:
  • erythromycin;
  • Tetracyclines:
  • tetracycline;
  • Quinolines:
  • nalidixic-acid;
  • Aminoglycosides:
  • amikacin; gentamicin; kanamycin; neomycin; streptomycin;
  • Heterocycles:
  • chloramphenicol; sulfadiazine; trimethoprim-sulfamethoxazole;
  • Miscellaneous antibiotics:
  • colistin;
  • novobiocin;

  • Aleksic, S., Heinzerling, F., & Bockemuhl, J. (1996). Human infection caused by Salmonellae of subspecies II to VI in Germany, 1977-1992. Zentralblatt Für Bakteriologie: International Journal of Medical Microbiology, 283(3), 391–398.

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Proteobacteria Class:  Gammaproteobacteria Order:  Enterobacterales Family:  Yersiniaceae Genus:  Yersinia Gram stain:  neg O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  vr Morphology:  Coccobacillus
    Health:  Unknown
    Source:  human faeces
    DNA G+C(%):  49.1
    Opt. T:  28-29℃
    		Aesculin:  neg Urea:  d Gelatin:  neg
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  neg L-Arabinose:  vr Glucose:  + Rhamnose:  neg Xylose:  + Cellubiose:  neg Lactose:  neg Maltose:  neg Melibiose:  d Sucrose:  + Trehalose:  + Amygdalin:  neg Adonitol:  neg D-Arabitol:  neg L-Arabitol:  neg Glycerol:  w Inositol:  neg Mannitol:  + Sorbitol:  + 5-Ketogluconate:  neg Me-α-D-Glc:  neg Salicin:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Melibiose:  neg Citrate:  w Mucate:  neg
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Urease:  d Ac-β-glcamnd:  neg α-Galactosidase:  + β-Galactosidase:  + α-Glucosidase:  neg β-Glucosidase:  neg β-Glucuronidase:  neg ArgDH:  neg LysDC:  neg OrnDC:  w Lipase:  neg
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		H2S:  neg Indole:  neg
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    ampicillin:  R(10; disc)
    aztreonam:  Sens
    carbenicil:  R(100; disc)
    penicillin_G:  R(10U)
    imipenem:  Sens
    cephalothin:  R(30; disc)
    amikacin:  Sens
    gentamicin:  S(10; disc)
    kanamycin:  S(30; disc)
    neomycin:  Sens
    streptomycin:  S(10; disc)
    erythromycin:  Res
    nalidixic-acid:  S(30; disc)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  S(30; disc)
    chloramphenicol:  S(30; disc)
    sulfadiazine:  S(250; disc, variable)
    SXT:  S(25; disc)
    novobiocin:  Res
    colistin:  S(10; disc)

    References

    SPECIFIC REFERENCES FOR YERSINIA ROHDEI
  • Eksic1987 - Yersinia rohdei sp. nov. Isolated from Human and Dog Feces and Surface Water.
  • Bottone2005Bergey - Bergey's manual of systematic bacteriology. Vol. 2, The Gammaproteobacteria Part B. Family Enterobacteriaceae, Genus XLI. Yersinia
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR YERSINIA ROHDEI
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • RajilicStojanovic2014 - The first 1000 cultured species of the human gastrointestinal microbiota.
  • ...............................
    • GENERAL REFERENCES FOR YERSINIA ROHDEI
  • CCUG - Culture Collection University of Gothenburg - Entire Collection
    • Added: April 08, 2021